CoChat

Glycemic Outcomes of Use of CLC Versus PLGS in Type 1 Diabetes: A Randomized Controlled Trial

Open access
Brown, Sue A., Beck, Roy W., Raghinaru, Dan, Buckingham, Bruce A., Laffel, Lori M., Wadwa, R. Paul, Kudva, Yogish C., Levy, Carol J., Pinsker, Jordan E., Dassau, Eyal, Doyle, Francis J., Ambler-Osborn, Louise, Anderson, Stacey M., Church, Mei Mei, Ekhlaspour, Laya, Forlenza, Gregory P., Levister, Camilla, Simha, Vinaya, Breton, Marc D., Kollman, Craig, Lum, John W., Kovatchev, Boris P., iDCL Trial Research Group, Kovatchev, Boris, Anderson, Stacey, Emory, Emma, Voelmle, Mary, Conshafter, Katie, Morris, Kim, Oliveri, Mary, Gondor-Fredrick, Linda, Mitchell, Harry, Calvo, Kayla, Wakeman, Christian, Breton, Marc, Laffel, Lori, Isganaitis, Elvira, Ambler-Osborn, Louise, Flint, Emily, Kim, Kenny, Roethke, Lindsay, Pinsker, Jordan, Church, Mei Mei, Andre, Camille, Piper, Molly, Levy, Carol, Lam, David, O’Malley, Grenye, Levister, Camilla, Ogyaadu, Selassie, Lovett, Jessica, Kudva, Yogish C., Simha, Vinaya, Dadlani, Vikash, McCrady-Spitzer, Shelly, Reid, Corey, Kumari, Kanchan, Wadwa, R. Paul, Forlenza, Greg, Alonso, G. Todd, Slover, Robert, Jost, Emily, Messer, Laurel, Berget, Cari, Towers, Lindsey, Rossick-Solis, Alex, Buckingham, Bruce, Ekhlaspour, Laya, Jacobson, Tali, Town, Marissa, Tabatabai, Ideen, Keller, Jordan, Salas, Evalina, Doyle, Francis, Dassau, Eyal, Lum, John, Beck, Roy, Passman, Samantha, Campos, Tiffany, Raghinaru, Dan, Kollman, Craig, Murphy, Carlos, Patibandla, Nandan, Borgman, Sarah, Arreza-Rubin, Guillermo, Eggerman, Thomas, Green, Neal, Kovatchev, Boris, Brown, Sue, Anderson, Stacey, Breton, Marc, Laffel, Lori, Pinsker, Jordan, Levy, Carol, Kudva, Yogish C., Wadwa, R. Paul, Buckingham, Bruce, Doyle III, Francis, Renard, Eric, Cobelli, Claudio, Reznik, Yves, Arreza-Rubin, Guillermo, Lum, John, Beck, Roy, Janicek, Robert, Gabrielson, Deanna, Belle, Steven H., Castle, Jessica, Green, Jennifer, Legault, Laurent, Willi, Steven M., Wysham, Carol, Eggerman, Thomas · 2020 · Diabetes Care
Cited by 55

The DOI matches its Crossref record; 5 of the 5 references it cites were found in a registry or an index.

Abstract

OBJECTIVE: Limited information is available about glycemic outcomes with a closed-loop control (CLC) system compared with a predictive low-glucose suspend (PLGS) system. RESEARCH DESIGN AND METHODS: After 6 months of use of a CLC system in a randomized trial, 109 participants with type 1 diabetes (age range, 14–72 years; mean HbA1c, 7.1% [54 mmol/mol]) were randomly assigned to CLC (N = 54, Control-IQ) or PLGS (N = 55, Basal-IQ) groups for 3 months. The primary outcome was continuous glucose monitor (CGM)-measured time in range (TIR) for 70–180 mg/dL. Baseline CGM metrics were computed from the last 3 months of the preceding study. RESULTS: All 109 participants completed the study. Mean ± SD TIR was 71.1 ± 11.2% at baseline and 67.6 ± 12.6% using intention-to-treat analysis (69.1 ± 12.2% using per-protocol analysis excluding periods of study-wide suspension of device use) over 13 weeks on CLC vs. 70.0 ± 13.6% and 60.4 ± 17.1% on PLGS (difference = 5.9%; 95% CI 3.6%, 8.3%; P < 0.001). Time >180 mg/dL was lower in the CLC group than PLGS group (difference = −6.0%; 95% CI −8.4%, −3.7%; P < 0.001) while time <54 mg/dL was similar (0.04%; 95% CI −0.05%, 0.13%; P = 0.41). HbA1c after 13 weeks was lower on CLC than PLGS (7.2% [55 mmol/mol] vs. 7.5% [56 mmol/mol], difference −0.34% [−3.7 mmol/mol]; 95% CI −0.57% [−6.2 mmol/mol], −0.11% [1.2 mmol/mol]; P = 0.0035). CONCLUSIONS: Following 6 months of CLC, switching to PLGS reduced TIR and increased HbA1c toward their pre-CLC values, while hypoglycemia remained similarly reduced with both CLC and PLGS.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.2337/dc20-0124

Cites

5 of 5 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Cited by

See all 55

Metadata

Authors
Brown, S. A., Beck, R. W., Raghinaru, D., Buckingham, B. A., Laffel, L. M., Wadwa, R. P., Kudva, Y. C., Levy, C. J., Pinsker, J. E., Dassau, E., Doyle, F. J., Ambler-Osborn, L., Anderson, S. M., Church, M. M., Ekhlaspour, L., Forlenza, G. P., Levister, C., Simha, V., Breton, M. D., Kollman, C., Lum, J. W., Kovatchev, B. P., iDCL Trial Research Group, Kovatchev, B., Anderson, S., Emory, E., Voelmle, M., Conshafter, K., Morris, K., Oliveri, M., Gondor-Fredrick, L., Mitchell, H., Calvo, K., Wakeman, C., Breton, M., Laffel, L., Isganaitis, E., Ambler-Osborn, L., Flint, E., Kim, K., Roethke, L., Pinsker, J., Church, M. M., Andre, C., Piper, M., Levy, C., Lam, D., O’Malley, G., Levister, C., Ogyaadu, S., Lovett, J., Kudva, Y. C., Simha, V., Dadlani, V., McCrady-Spitzer, S., Reid, C., Kumari, K., Wadwa, R. P., Forlenza, G., Alonso, G. T., Slover, R., Jost, E., Messer, L., Berget, C., Towers, L., Rossick-Solis, A., Buckingham, B., Ekhlaspour, L., Jacobson, T., Town, M., Tabatabai, I., Keller, J., Salas, E., Doyle, F., Dassau, E., Lum, J., Beck, R., Passman, S., Campos, T., Raghinaru, D., Kollman, C., Murphy, C., Patibandla, N., Borgman, S., Arreza-Rubin, G., Eggerman, T., Green, N., Kovatchev, B., Brown, S., Anderson, S., Breton, M., Laffel, L., Pinsker, J., Levy, C., Kudva, Y. C., Wadwa, R. P., Buckingham, B., Doyle III, F., Renard, E., Cobelli, C., Reznik, Y., Arreza-Rubin, G., Lum, J., Beck, R., Janicek, R., Gabrielson, D., Belle, S. H., Castle, J., Green, J., Legault, L., Willi, S. M., Wysham, C., & Eggerman, T.
Venue
Diabetes Care
Published
2020-05-29
Volume
43
Issue
8
Pages
1822-1828
ISSN
  • 0149-5992 (ISSN-L)
  • 1935-5548
OpenAlex
W3031073495
Cited by
55
References
5
FWCI
5.89
Type
journal article
Language
en
Open access
green

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.